Insider filing · REGN
Marion McCourt
EVP Commercial
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 35 filings in 24 months
ticker →
Marion McCourt sold $845K of Regeneron Pharmaceuticals (REGN)
Executed Nov 1 2024, disclosed Nov 5 2024, 4 days later.
Value, as filed
$845K
1,000 sh × $844.61
Executed
Nov 1 2024
the trade date, as filed
Disclosed
Nov 5 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MMMarion McCourt (EVP Commercial) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $984K of REGN (1,132 sh × $869.43, as filed), executed Oct 30.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Marion McCourt in REGN
REGNSALE
Regeneron Pharmaceuticals, Inc.
$984K1,132 sh × $869.43
Exec Oct 30
Filed Nov 3 · 4:02 PM ET